Fused bicyclic 2,4-diaminopyrimidine derivative as a dual ALK and FAK inhibitor
US9623026B2 · kind B2 · utility
2Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2016 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | May 4, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I)or a salt form thereof. The compound of formula (I) has ALK and FAK inhibitory activity, and may be used to treat proliferative disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.